Researchers Identify Six Distinct Symptom Cluster ‘types’ of COVID-19
Analysis of data from the COVID Symptom Study app, led by researchers from King’s College London, reveals that there are six distinct ‘types’ of COVID-19, each distinguished by a particular cluster of symptoms. Moreover, the team found that these types…
COVID-19 may spark diabetes in healthy individuals
Well-respected academics from around the world speculate that COVID-19 not just a risk for diabetic patients, but is also capable of triggering diabetes in healthy people. COVID-19 first erupted in Wuhan, China late last year. Since then scientists are still…
Dual attack: A synthetic peptide could work as a treatment and vaccine for COVID-19.
Ligandal has succeeded in applying its unique peptide-based technology to develop a synthetic peptide acting as both an antidote and a vaccine against COVID-19. With the whole world racing to find a treatment or vaccine against COVID-19, San Francisco based…
Is Dexamethasone an alternative in fight against COVID-19?
Dexamethasone low cost, anti-inflammatory steroid well known in the world of sports is the first drug to reduce death among COVID-19 patients. One of the common symptoms seen among COVID-19 patients is shortness of breath or respiratory failure. Recently, promising…
Advancements in serologic diagnostic tests could put an end to the COVID-19 test crisis
The University of Bologna along with Roche and Hitachi are working on making faster, cheaper diagnostic tests for COVID-19 with the help of electrochemiluminescence (ECL). Currently one of the main reasons for the rising number of COVID-19 cases is due…
Does the current COVID-19 pandemic resemble the 1918 Spanish flu?
With the number of COVID-19 increasing every day, and no treatment available, governments’ options are limited to social distancing and learning from the past. Here’s how COVID-19 resembles the 1918 Spanish Flu. With several countries easing down the lockdown, concerns…
COVID19: AstraZeneca & Serum Institute of India collaborate to sign a deal for 1 billion doses of the novel Oxford University vaccine
The new Oxford University vaccine AZD 1222 shows promising results in COVID-19 patients. A deal signed by AstraZeneca and Serum Institute of India promises a billion doses of the vaccine for middle and low-income countries. With COVID-19 claiming its share…
COVID-19: Can a novel flu drug be the breakthrough we all need?
With certain COVID-19 symptoms resembling the common flu, experts wonder if a new anti-flu drug- Baloxavir may be the solution we have all been waiting for. The entire world is currently battling against COVID-19, as the number of confirmed cases…
Premas biotech announced the completion of their vaccine prototype against COVID-19.
With the race against COVID-19 building tension among the healthcare sector, India based biotech company, Prema Biotech announces successful completion of their vaccine prototype against COVID-19 using inhouse D-crypt technology. With COVID-19 infecting millions and claiming over 300,00 lives all…
